Results 11 to 20 of about 4,373 (200)
Lambert-Eaton myasthenic syndrome: the 60th anniversary of Eaton and Lambert's pioneering article
This historical review describes the contribution of Drs. Lee M. Eaton and Edward H. Lambert to the diagnosis of myasthenic syndrome on the 60th anniversary of their pioneering article (JAMA 1957) on the disease.
Paulo José Lorenzoni +3 more
doaj +3 more sources
Lung adenocarcinoma with Lambert–Eaton myasthenic syndrome indicated by voltage-gated calcium channel: a case report [PDF]
Introduction Lambert–Eaton myasthenic syndrome is a rare disorder and it is known as a paraneoplastic neurological syndrome. Small cell lung cancer often accompanies this syndrome.
Arai Hiromasa +10 more
doaj +2 more sources
Lambert-Eaton myasthenic syndrome: report of two cases [PDF]
Two cases of Lambert-Eaton myasthenic syndrome, in female patients whose neoplasm investigation was negative, are reported. Repetitive stimulation of ulnar nerve showed an incremental response (+187% and +198%).
ROSANA H. SCOLA +8 more
doaj +2 more sources
Lambert-Eaton Syndrome in Children
Investigators from Boston Children's Hospital; the Lahey Clinic, Burlington, MA; and Ohio State University, report 3 children presenting between ages 9 and 10 years with proximal lower extremity weakness with areflexia and low-amplitude compound muscle ...
J Gordon Millichap, John J Millichap
doaj +2 more sources
Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome
Lambert-Eaton myasthenic syndrome (LEMS) is a paraneoplastic neuromuscular junction disorder. LEMS presents with muscular weakness and fatigability, mainly involving the proximal lower limbs.
Sumera Bukhari MD +4 more
doaj +2 more sources
The Lambert-Eaton Myasthenic Syndrome
The Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disease of the neuromuscular junction. The main symptom in LEMS is proximal muscle weakness in the legs, which is the presenting symptom in most patients. Autonomic dysfunction is also part of the clinical spectrum.
Wirtz, Paul W. +2 more
openaire +3 more sources
The association between Lambert–Eaton myasthenic syndrome and small cell lung carcinoma
Sarah EW Briggs,1 Paul Gozzard,2 Denis C Talbot31Department of Oncology, Oxford University Hospitals Trust, Churchill Hospital, Oxford, UK; 2Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford UK ...
Briggs SEW, Gozzard P, Talbot DC
doaj +1 more source
Lambert-Eaton Myasthenic Syndrome in Lung Cancer. [PDF]
The aim is to study lung cancer with Lambert‐Eaton myasthenic syndrome (LEMS) with clinical and electrical characteristics of physiology and prognosis. Fourteen LEMS patients with lung cancer were studied retrospectively. The data including demographics, clinical presentation, treatments, and prognosis from the medical records were analyzed.
Wang Y +7 more
europepmc +3 more sources
Lambert-Eaton myasthenic syndrome [PDF]
SummaryThe Lambert-Eaton myasthenic syndrome is a neuromuscular disorder characterised by defective neurotransmitter release at autonomic neurones and presynaptic terminals of the neuromuscular junction. It is caused by an IgG autoantibody formed against especially the P/Q type of voltage-gated calcium channels (VGCC) which is an essential component of
U, Seneviratne, R, de Silva
openaire +3 more sources
Lambert-Eaton Myasthenic Syndrome
Lambert-Eaton myasthenic syndrome is a disorder of neuromuscular transmission in which an autoantibody is directed against the pre-synaptic calcium channel. It presents with proximal limb weakness, greater in the legs, with or without peripheral and autonomic neuropathy. Bulbar involvement is rare and fatigueability is not a feature.
Jayarangaiah A +2 more
europepmc +12 more sources

